clinical trials

See the following -

Vast Study Casts Doubts On Value Of Mammograms

Gina Kolata | New York Times | February 11, 2014

One of the largest and most meticulous studies of mammography ever done, involving 90,000 women and lasting a quarter-century, has added powerful new doubts about the value of the screening test for women of any age. Read More »

WATCH: What Doctors Don't Know About The Drugs They Prescribe

Ben Goldacre | Huffington Post | April 5, 2013

TEDTalks can sometimes portray science in triumphalist tones, with fabulous innovations that are changing the world forever. But the real action in science is often around dirty, messy, angry problems, and my TEDTalk is about the dirtiest I've seen yet. Read More »

When It Comes to Pharmaceuticals and Medical Devices, We Should Ask More and Listen Better

A new study in JAMA suggests that nearly one-in-three drugs approved by the FDA between 2001 and 2010 had post-market safety issues, which caused safety communications to physicians and consumers, "black-box" warnings on labels, and drug withdrawals. It is not clear how many patients may have died or otherwise harmed by these issues...Lead author Joseph Ross, M.D., noted: "No drug is completely safe, and during premarket evaluation, we are not going to pick up all the safety signals," and urged "that we have a strong system in place to continually evaluate drugs and to communicate new safety concerns quickly and effectively."

Read More »

Why All Pharmaceutical Research Should Be Made Open Access

Cory Doctorow | The Guardian | November 20, 2012

The government wants to make all publicly funded research available – but the same must be demanded of pharmas also Read More »

Why Branding Obesity As A Disease Is A Step In The WRONG Direction...

Joseph Mercola | | July 6, 2013

The documentary film Hungry For Change1 is another revolutionary look at food and nutrition from the creators of the best-selling film Food Matters. Read More »

Why Open Source Is the Future of Clinical Trials

Clinovo is a Clinical Research Organization (CRO) that partners with life science companies to streamline their clinical trials. Their CTO Marc Desgrousilliers is managing the development of ClinCapture, their open source Electronic Data Capture (EDC) system. In this interview, he tells us more about why healthcare needs open source and why it is the future of clinical trials... Read More »

Why Opening Up Clinical Trials Data Is Good For Pharma Companies

Glyn Moody | TechDirt | November 5, 2013

Earlier this year we wrote about how AbbVie, the pharma company spun out of Abbott Laboratories, had gone to court to stop the European Medicines Agency (EMA) from releasing clinical trials information about one of its drugs. Read More »

Why You Might Want To Swap Out Your Low-Fat Diet For A Mediterranean One

Staff Writer | Huffington Post | February 8, 2014

When it comes to maintaining a healthy heart, eating more in line with a Mediterranean diet may do you more good than a strictly low-fat one, according to a new review of studies. Read More »

Yale Program's Agreement With Johnson & Johnson Allows Broad Access To Clinical Trial Data

Press Release | Yale University Open Data Access (YODA) Project, Johnson & Johnson (J&J) | January 30, 2014

In a move that promotes open science, the Yale University Open Data Access (YODA) Project has entered an agreement with Johnson & Johnson that will enable scientists around the world to gain access to the company's clinical trial data assets. Read More »

Yale Program’s Agreement With Johnson & Johnson Allows Broad Access To Clinical Trial Data

Karen N. Peart | Yale News | January 30, 2014

In a move that promotes open science, the Yale University Open Data Access (YODA) Project has entered an agreement with Johnson & Johnson that will enable scientists around the world to gain access to the company’s clinical trial data assets. Read More »

YODA Project: 'Opening Up' Clinical Trials & Research Practices

Many patients and their physicians often make treatment decisions with access to only a fraction of the relevant clinical research data because details about many clinical studies or clinical trials are never made available in published biomedical literature. The YODA Project may change this. Read More »

23rd Annual Partnerships in Clinical Trials Conference

Event Details
March 30, 2014 - 8:00am - April 2, 2014 - 5:00pm
The Mirage
3400 S Las Vegas Blvd
Las Vegas, NV 89109
United States

The 23rd Annual Partnerships in Clinical Trials event is North America's largest conference serving the global clinical trials, operations and outsourcing community..
Delegates from all parts of the clinical trial value chain come to Partnerships in Clinical Trials to quickly identify, engage and enter into strategic relationships that drive their clinical trials successfully forward as well as take part in the 60+ sessions and workshops geared to focus on several topic areas of interest including but not limited to risk-based monitoring, strategic sourcing, emerging market, patient adherence, and more. This year's Partnerships in Clinical Trials event will again draw upwards of 1,300 industry attendees for four days of high level networking, idea exchange, and innovation. Read More »

DIA 2014 50th Annual Meeting To Highlight TransCelerate BioPharma Collaboration

Event Details
June 15, 2014 (All day) - June 19, 2014 (All day)
San Diego Convention Center
111 W Harbor Drive
San Diego, CA 92101
United States

Industry leaders in R&D will examine accomplishments, progress and 2014 line extensions. Susan Cantrell, senior vice president and managing director for DIA Americas, will chair the panel discussion “Collaboration in R&D: What’s New for TransCelerate BioPharma?” during DIA’s 2014 50th Annual Meeting at the San Diego Convention Center from June 15 to 19...

Read More »

Setting Up Early Stage Clinical Trials

Event Details
June 1, 2016 - 6:00pm - 7:30pm
Hewlett Packard
1501 Page Mill Rd Building 5
Palo Alto, CA 94304
United States

The number of registered clinical trials has been increasing steadily from 83,000 in 2010 to 210,000 in March 2016 (33,000 of which are Phase 0 and I studies) while R&D spending for clinical trials has not grown as rapidly...With 17% of registered clinical trials being early phase studies, we asked experts from the sponsor and CRO worlds to share their knowledge on how to best set up and manage early stage clinical trials to meet this difficult environment. They will explore some of the challenges small and start-up biotechs face when launching clinical development programs:

Read More »